Paper Details

  1. Home
  2. Paper Details

[Experience with Prasugrel in the Treatment of Patients with Acute Coronary Syndrome].

Author: AvetisyanE A, MerkulovaIrina Alekseevna, StaroverovI I

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is a standard treatment for acute coronary syndrome (ACS). This review explores the various DAPT regimens and the associated risks and benefits.
Paper Details　
Original Abstract of the Article :
Dual antiplatelet therapy (DAPT) with aspirin and one of inhibitors of P2Y12 receptors (clopidogrel, ticagrelor, prasugrel) is an international standard of receptors (clopidogrel, ticagrelor, prasugrel) is an international standard of is an international standard of treatment strategy in patients wi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.18087/cardio.2019.6.n544

データ提供：米国国立医学図書館（NLM）

The Role of Prasugrel in Treating Acute Coronary Syndrome: A New Oasis in the Desert of Heart Disease

The treatment of acute coronary syndrome (ACS) is a challenging expedition in the vast desert of heart disease. This study explores the role of prasugrel, a potent antiplatelet medication, in managing ACS, particularly in the context of dual antiplatelet therapy (DAPT). This research is like a camel caravan, navigating the desert of heart disease, seeking a safe and effective path to protect travelers from the threat of heart attack.

A Powerful Weapon: Prasugrel in DAPT

The study underscores the importance of DAPT, a combination therapy involving aspirin and a P2Y12 receptor inhibitor like prasugrel, in managing ACS. It's like discovering a powerful weapon in the desert of heart disease, combining the forces of different medications to protect against heart attack. This research is like a map, guiding us towards a more comprehensive and effective approach to managing ACS, considering the unique needs of each patient.

A Safer Journey Through the Desert: A Beacon of Hope

This study highlights the potential benefits of prasugrel in DAPT, providing a safer and more effective strategy for managing ACS. This research is like a beacon of hope in the desert of heart disease, offering a more personalized and patient-centered approach to treatment. The authors emphasize the need for careful monitoring and individualized treatment plans to ensure optimal outcomes for patients with ACS.

Dr.Camel's Conclusion

This study represents a significant step forward in the treatment of ACS, highlighting the importance of DAPT and the potential benefits of prasugrel. This research is like a wellspring of knowledge in the desert of heart disease, guiding us towards a brighter future for patients facing this challenging condition. As we continue to explore the depths of this research, we may discover new oases of knowledge, leading us closer to effective and personalized treatments for all.
Date :
  1. Date Completed 2019-07-09
  2. Date Revised 2019-07-09
Further Info :

Pubmed ID

31242837

DOI: Digital Object Identifier

10.18087/cardio.2019.6.n544

SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.